| Literature DB >> 32456255 |
Silvana Alfei1, Anna Maria Schito2.
Abstract
Antibiotic resistance has increased markedly in Gram-negative bacteria, causing severe infections intractable with traditional drugs and amplifying mortality and healthcare costs. Consequently, to find novel antimicrobial compounds, active on multidrug resistant bacteria, is mandatory. In this regard, cationic antimicrobial peptides (CAMPs)-able to kill pathogens on contact-could represent an appealing solution. However, low selectivity, hemolytic toxicity and cost of manufacturing, hamper their massive clinical application. In the recent years-starting from CAMPs as template molecules-less toxic and lower-cost synthetic mimics of CAMPs, including cationic peptides, polymers and dendrimers, have been developed. Although the pending issue of hemolytic toxicity and biodegradability is still left not completely solved, cationic antimicrobial polymers (CAPs), compared to small drug molecules, thanks to their high molecular weight, own appreciable selectivity, reduced toxicity toward eukaryotic cells, more long-term activity, stability and non-volatility. With this background, an updated overview concerning the main manufactured types of CAPs, active on Gram-negative bacteria, is herein reported, including synthetic procedure and action's mechanism. Information about their structures, antibacterial activity, advantages and drawbacks, was reported in the form of tables, which allow faster consultation and quicker learning concerning current CAPs state of the art, in order not to retrace reviews already available.Entities:
Keywords: Gram-negative bacteria; antibiotic resistance; hemolytic cytotoxicity; membrane disruption; positively charged polymers
Year: 2020 PMID: 32456255 PMCID: PMC7285334 DOI: 10.3390/polym12051195
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Structure of colistin.
Figure 2Number of publications as a function of time that contain the phrase “antimicrobial polymer” via Scopus. These data include the cationic antimicrobial polymers literature (the scope of this review).
Figure 3Examples of cationic antimicrobial peptides (CAMPs) not susceptible to develop resistance: (a) Structure of tachyplesin II; (b) structure of cecropin P1.
Categories of antimicrobial polymer systems.
| Category | Description | Action | Advantages | Drawbacks | |
|---|---|---|---|---|---|
| biocidal polymer | necessarily | quaternary phosphonium | unspecific electrostatic/disruptive interaction with negatively charged bacteria membranes | no presence of toxic biocide | hemolytic toxicity |
| guanidinium | |||||
| tertiary sulfonium | |||||
| primary, secondary, tertiary, quaternary ammonium | |||||
| biocidal polymers embodied | |||||
| polymeric biocide | from polymerization of antimicrobial monomers | same action of the attached biocide moieties | lower systemic toxicity | less active than free biocide drugs for steric hindrance cause by polymer | |
| biocide-releasing polymer | unnecessary cationic | by releasing the entrapped or bond antimicrobial drugs | target release of biocide | significant reduction of activity in time | |
Examples of Gram-negative bacteria.
| Family | Genus | Species |
|---|---|---|
| Campylobacteraceae |
|
|
|
|
| |
| Enterobacteriaceae |
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
| ||
|
|
| |
|
|
| |
|
|
| |
| Moraxellaceae |
|
|
|
|
| |
| Neisseriaceae |
|
|
|
|
| |
| Pasteurellaceae |
|
|
| Pseudomonadaceae |
|
|
| Vibrionaceae |
|
Figure 4Schematic representation of the structure of the cell wall of Gram-negative bacteria.
Characteristics of Gram-negative bacteria cell walls.
| Possible Constituents of the Bacteria Outer Envelope | Gram-Negative Bacteria | Features | Components | |
|---|---|---|---|---|
| inner cell cytoplasmic membrane (CM) | present | negatively charged | phospholipid bilayer | |
| peptidoglycan | present | much thicker that in Gram-positive bacteria | sugars ( | |
| outer membrane (OM) | present | high density of negative charges | lipopolysaccharide | lipid A |
| polysaccharide core | ||||
| O antigen | ||||
| phospholipids membrane proteins | ||||
| lipoproteins | single-layer phospholipid | |||
| hydrophilic proteins | ||||
| porins | pores for particular molecules | |||
| periplasmic space | present | concentrated gel-like substance | periplasm | |
| surface layer | present | directly attached to OM | proteins | |
| flagella | possibly present | four supporting rings instead of two | helical protein flagellin with the shape of a 20-nanometer-thick hollow tube | |
| lipoteichoic acids | absent | molecules that completely cross the wall linked to phospholipids or to peptidoglycan | polyvalent alcohol polymers bonded together through a phosphate group | |
| Braun’s lipoprotein | possibly present | link between the OM and the peptidoglycan chain by a covalent bond | hydrophilic protein | |
Comparison between the interaction steps of small molecule antimicrobial agents and cationic antimicrobial polymers (CAPs).
| Step | Small Molecule | CAPs |
|---|---|---|
| initial absorption | weak | strong |
| diffusion past the cell wall | strong | weak |
| binding into the membrane | weak | strong |
| disruption and disintegration of the membrane | weak | strong |
Natural and synthetic antimicrobial cationic polymers active on Gram-negative bacteria developed in the last decades.
| Structure of Cationic Polymer | Target Bacteria | Antibacterial Activity Expressed as | Drawbacks | Advantage | Sectors of Application/Uses |
|---|---|---|---|---|---|
| 20–1000 | difficult control over structure and properties | biocompatible | agriculture sector | ||
|
| > 128 | difficult control over structure and properties | biocompatible | pharmaceutic | |
|
| 1–10 | difficult control over structure and properties | water soluble | food sector | |
|
| 10–33 | activity reduced by organic material as blood | chemical stability | disinfection of surfaces disinfection in hospital, nursing homes, public places | |
|
| 1.5 | activity reduced by organic material as blood | chemical stability | disinfection of non-critical surfaces | |
|
| inactive | limited activity | chemical stability | disinfection of non-critical surfaces | |
|
| inactive | limited activity | chemical stability | no practical application | |
|
| 2.5–6.1 | activity reduced by organic material as blood | chemical stability | disinfection of non-critical surfaces: | |
|
| 0.8–0.9 | limited activity | chemical stability | no practical application | |
|
| inactive | limited activity | chemical stability | disinfection of non-critical surfaces | |
|
| 5.7–6.1 | activity reduced by organic material as blood | chemical stability | disinfection of non-critical surfaces | |
|
| 3.9–60 | activity reduced by organic material as blood | dual-functional chemical stability | medical device coatings | |
|
| 75–250 1 | activity reduced by organic material as blood | dual-functional device | flocculant and | |
|
| 10–100 | activity reduced by organic material as blood | chemical stability | disinfectants | |
|
| > 50 | no activity in liquid-medium assay | antimicrobial activity in an agar-plate assay | disinfectants | |
|
| 25 | highly hemolytic | high activity | disinfection of non-critical surfaces | |
|
| residual cytotoxicity | considerable activity | food industry | ||
|
| 4–8 5 | low biocompatibility | High activity | disinfectants not suitable for clinical applications | |
|
| 16–32 5 | non-tuberculocidal | High activity | promising antimicrobials with potential for clinical applications | |
|
| > 1500 | poor activity | Low hemolytic toxicity | promising for producing antimicrobial surface for use in biomedical devices | |
|
| 40 | limited spectrum of action | Non-irritative for skin | disinfection of non-critical surfaces in hospital, nursing homes, public places | |
|
| 0.29–1.25 2 | non-tuberculocidal | non-irritative for skin | ||
| 2–8 | non-tuberculocidal | high antibacterial activity | permanent sterile-surface materials for hospital infection control | ||
|
| 15–125 1,5 | non-tuberculocidal | chemical stability | for use in areas of medicine | |
|
| 7–62 1,5 | non-tuberculocidal | chemical stability | for use in areas of medicine | |
|
| 5 5 | non-tuberculocidal | no hemolytic activity | for use in areas of medicine | |
|
| 400 | poor activity | high selectivity | not signaled | |
|
| 25 | low selectivity | high ability in inserting in CM high ability in disrupting CM high effectiveness | potential antimicrobial agents with low clinical applicability | |
|
| 6 | non-tuberculocidal | bactericidal | biomedicine | |
|
| 50 | less active than magainin (AMP) | potential antimicrobial agents | ||
|
| 4–200 | high cytotoxicity for achieving good activity | tunable activity tunable selectivity | potential antimicrobial agents with low clinical applicability | |
|
| 31–63 | poor activity against fungi | broad spectrum | development of antimicrobial agents for clinical applications | |
|
| 5–70 5,10 | biocompatibility depending on VP content | tunable biocompatibility | permanent bactericidal-surface materials for hospital infection control | |
|
| 8 | non-tuberculocidal | tunable bactericidal activity | sterile-surface | |
|
| 74–96 (glass) | non-tuberculocidal | significant to total | permanent bactericidal-surface materials for hospital infection control | |
|
| 60–100 | non-tuberculocidal | chemical stability | not suitable for clinical applications |
*Natural polymers; § antimicrobial activity is expressed as log reduction of bacteria population; # activity is expressed as antibacterial efficiency (%); 1 depending on PTPB content; 2 depending on MW; 3 R = methyl; 4 R = butyl; 5 MBC is given; 6 ceftazidime resistant; 7 multidrug resistant; 8 ciprofloxacin and levofloxacin resistant; 9 the minimal concentration for reduction of CFU counting to one; 10 depending on VP content.
Figure 5Quaternized chitosan derivatives permanently cationic: (a) Chitosan phosphonium salt; (b) o-quaternary chitosan ammonium salts. R: –CH2Ph (BNQAS–CS); –C12H25 (C12QAS–CS); – C14H29 (C14QAS–CS); – C16H33 (C16QAS–CS); – C18H37 (C18QAS–CS); X: Cl, Br.
Variations in the antimicrobial activity of some CAPs in function of variations in MW and alkyl chains length.
| Type of CAPs | MW | Alkylation | Antimicrobial Activity |
|---|---|---|---|
| oligomeric guanidinium | ↓MW | ↓activity [ | |
| quaternized | 160,000 | full bactericidal effect [ | |
| quaternized | 25,000 | full bactericidal effect [ | |
| quaternized poly(2-(dimethylamino)ethyl | Mn >10,000 | 100% killing efficiency [ | |
| secondary and tertiary | ↑MW | ↓MIC100 [ | |
| poly | alkyl C12 chain | ↑activity [ | |
| cationic quaternary | any length | not influenced by the length | |
| alkylated quaternized PVP polymers | alkyl > C6 chain | ↓activity [ | |
| quaternized poly (4-vinyl pyridine) (P4VP)-poly (vinylidene fluoride) | C4>chain< C10 | ↑activity [ | |
| quaternized alkyl pyridinium polyoxanorbornene | Chain < C4 | minimal activity [ | |
| quaternized alkyl pyridinium polyoxanorbornene | Chain > C6 | ↑activity [ |
Correlations between polymers structural properties, antimicrobial activity and toxicity.
| Type of CAP | CAP Structural Properties | Hemolysis (H) | Antimicrobial Activity |
|---|---|---|---|
| quaternized pyridinium–methacrylate copolymers | charge spatially separates by alkyl tails | ↑H | ↑ [ |
| hydrophilic | use of strongly hydrophilic comonomers (HEMA or PEGMA) | ↓H,C | ↑ [ |
| quaternized PVP | use of hydrophilic comonomers | ↓H | ↑ [ |
| larger size | no appreciable | ↑ [ | |
| polystyrene-based ammonium polymers | protonated tertiary amine groups | not available | ↑ [ |
| polystyrene-based ammonium polymers | quaternized ammonium groups | not available | ↓ [ |
| random amphiphilic methacrylamide-based | protonated primary amine groups | minimal | ↑ [ |
| random amphiphilic methacrylamide-based | protonated tertiary amine groups | minimal | ↑ [ |
| random amphiphilic methacrylamide-based | quaternized ammonium groups | considerable | ↓ [ |
| Water-soluble | protonated secondary or tertiary amine groups | not available | ↑ [ |
| quaternized ammonium groups | quaternized ammonium groups | not available | ↓ [ |
| poly(diallylammonium trifluoroacetate) | protonated secondary amine groups | not available | ↑ [ |
| poly(diallylammonium trifluoroacetate) | quaternary ammonium groups | not available | ↓ [ |
| quaternized alkyl pyridinium polyoxanorbornene | chain < C4 | low | ↓ [ |
| quaternized alkyl pyridinium polyoxanorbornene | chain > C6 | considerable | ↑ [ |
1 compared to the not quaternized polymers reported in the previous row.